CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
4.44
2.2%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.08
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026207 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026207%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003985 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003985%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 4.54
Open* 4.4
1-Year Change* -31.89%
Day's Range* 4.25 - 4.44
52 wk Range 4.26-7.84
Average Volume (10 days) 13.61K
Average Volume (3 months) 365.10K
Market Cap 35.65M
P/E Ratio -100.00K
Shares Outstanding 7.75M
Revenue 16.29M
EPS -0.81
Dividend (Yield %) N/A
Beta 0.60
Next Earnings Date Feb 19, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 8, 2023 4.54 0.15 3.42% 4.39 4.54 4.39
Dec 7, 2023 4.45 0.03 0.68% 4.42 4.49 4.42
Dec 6, 2023 4.45 0.00 0.00% 4.45 4.55 4.37
Dec 5, 2023 4.44 -0.01 -0.22% 4.45 4.45 4.37
Dec 4, 2023 4.47 0.03 0.68% 4.44 4.47 4.44
Dec 1, 2023 4.44 -0.04 -0.89% 4.48 4.50 4.44
Nov 30, 2023 4.53 0.03 0.67% 4.50 4.59 4.49
Nov 29, 2023 4.63 -0.06 -1.28% 4.69 4.71 4.59
Nov 28, 2023 4.52 -0.08 -1.74% 4.60 4.60 4.49
Nov 27, 2023 4.62 -0.13 -2.74% 4.75 4.85 4.62
Nov 24, 2023 4.60 -0.05 -1.08% 4.65 4.74 4.55
Nov 22, 2023 4.49 0.05 1.13% 4.44 4.54 4.44
Nov 21, 2023 4.54 -0.16 -3.40% 4.70 4.70 4.26
Nov 20, 2023 4.61 0.01 0.22% 4.60 4.70 4.55
Nov 17, 2023 4.75 0.05 1.06% 4.70 4.78 4.70
Nov 16, 2023 4.66 -0.07 -1.48% 4.73 4.79 4.57
Nov 15, 2023 5.01 -0.01 -0.20% 5.02 5.22 5.00
Nov 14, 2023 5.24 -0.05 -0.95% 5.29 5.29 4.75
Nov 13, 2023 5.19 0.09 1.76% 5.10 5.36 5.08
Nov 10, 2023 5.18 -0.12 -2.26% 5.30 5.38 5.17

ImmuCell Events

Time (UTC) Country Event
Monday, February 19, 2024

Time (UTC)

21:00

Country

US

Event

Q4 2023 ImmuCell Corp Earnings Release
Q4 2023 ImmuCell Corp Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 18.568 19.243 15.3422 13.7229 10.9863
Revenue 18.568 19.243 15.3422 13.7229 10.9863
Cost of Revenue, Total 10.9192 10.587 8.47938 6.98315 5.79239
Gross Profit 7.64878 8.65593 6.86282 6.73972 5.19391
Total Operating Expense 20.8669 18.9856 15.8796 14.6768 12.4329
Selling/General/Admin. Expenses, Total 5.45385 4.23003 3.88855 4.00602 3.82386
Research & Development 4.49387 4.16852 4.35463 3.68761 3.51662
Operating Income -2.29895 0.25739 -0.53744 -0.95391 -1.44657
Interest Income (Expense), Net Non-Operating -0.19544 -0.29555 -0.29047 -0.31351 -0.41348
Other, Net 0.00091 0 -0.16505 0
Net Income Before Taxes -2.48613 -0.06913 -1.03225 -1.26741 -1.86005
Net Income After Taxes -2.49381 -0.07829 -1.02212 -1.29559 -2.32167
Net Income Before Extra. Items -2.49381 -0.07829 -1.02212 -1.29559 -2.32167
Net Income -2.49381 -0.07829 -1.02212 -1.29559 -2.32167
Income Available to Common Excl. Extra. Items -2.49381 -0.07829 -1.02212 -1.29559 -2.32167
Income Available to Common Incl. Extra. Items -2.49381 -0.07829 -1.02212 -1.29559 -2.32167
Dilution Adjustment
Diluted Net Income -2.49381 -0.07829 -1.02212 -1.29559 -2.32167
Diluted Weighted Average Shares 7.74512 7.59229 7.21333 6.81896 5.48615
Diluted EPS Excluding Extraordinary Items -0.32198 -0.01031 -0.1417 -0.19 -0.42319
Diluted Normalized EPS -0.3226 -0.00766 -0.21411 -0.19 -0.50612
Total Extraordinary Items
Unusual Expense (Income) -0.84292 -0.7
Gain (Loss) on Sale of Assets 0.00733 -0.03096 -0.0393
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 3.53268 3.44653 3.91088 4.79603 9.86106
Revenue 3.53268 3.44653 3.91088 4.79603 9.86106
Cost of Revenue, Total 2.48879 3.14575 2.9187 2.94997 5.05051
Gross Profit 1.04389 0.30078 0.99218 1.84606 4.81055
Total Operating Expense 4.83718 5.70257 5.54463 5.41282 9.90946
Selling/General/Admin. Expenses, Total 1.24885 1.44645 1.57652 1.19308 2.68425
Research & Development 1.09954 1.11037 1.04941 1.26976 2.1747
Operating Income -1.3045 -2.25604 -1.63375 -0.61679 -0.0484
Interest Income (Expense), Net Non-Operating -0.07377 -0.04935 -0.02893 -0.03442 -0.13207
Gain (Loss) on Sale of Assets 0.00008 -0.00824 -0.00367 0 0.011
Other, Net 0 0.00011 0 0.00091
Net Income Before Taxes -1.37819 -2.31353 -1.66636 -0.65121 -0.16857
Net Income After Taxes -1.37971 -2.31505 -1.66787 -0.65508 -0.17086
Net Income Before Extra. Items -1.37971 -2.31505 -1.66787 -0.65508 -0.17086
Net Income -1.37971 -2.31505 -1.66787 -0.65508 -0.17086
Income Available to Common Excl. Extra. Items -1.37971 -2.31505 -1.66787 -0.65508 -0.17086
Income Available to Common Incl. Extra. Items -1.37971 -2.31505 -1.66787 -0.65508 -0.17086
Diluted Net Income -1.37971 -2.31505 -1.66787 -0.65508 -0.17086
Diluted Weighted Average Shares 7.74686 7.74686 7.74689 7.74686 7.7457
Diluted EPS Excluding Extraordinary Items -0.1781 -0.29884 -0.2153 -0.08456 -0.02206
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.17811 -0.29815 -0.21499 -0.08456 -0.02298
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 13.9948 16.2649 12.157 13.189 6.42084
Cash and Short Term Investments 5.79156 10.1855 7.94643 8.77405 2.52105
Cash & Equivalents 5.79156 10.1855 6.94994 6.29329 2.52105
Short Term Investments 0 0.9965 2.48075
Total Receivables, Net 1.80078 2.72071 1.86442 1.6777 0.9323
Accounts Receivable - Trade, Net 1.7586 2.69423 1.7968 1.63717 0.9323
Total Inventory 6.03854 3.08997 2.09251 2.51826 2.33167
Prepaid Expenses 0.36388 0.26871 0.25284 0.21823 0.63582
Other Current Assets, Total 0 0.0008 0.0008
Total Assets 44.8606 44.4657 40.3496 38.6918 32.7308
Property/Plant/Equipment, Total - Net 30.6364 28.0027 27.9753 25.2657 26.0275
Goodwill, Net 0.09556 0.09556 0.09556 0.09556 0.09556
Intangibles, Net 0.05731 0.07642 0.09552 0.11462 0.13373
Long Term Investments
Other Long Term Assets, Total 0.07663 0.02612 0.02617 0.02688 0.05316
Total Current Liabilities 3.07207 2.53447 2.21108 2.49536 2.56501
Payable/Accrued 1.22066
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 1.03945 0.81221 0.76034 1.27479 1.34435
Other Current Liabilities, Total 0.14876 0.20122 0.13748 0.17511 0
Total Liabilities 14.4806 11.8888 12.0834 9.70056 10.9865
Total Long Term Debt 9.19111 8.32712 8.73715 7.14668 8.42149
Long Term Debt 9.19111 8.32712 8.73715 7.14668 8.42149
Other Liabilities, Total 2.21742 1.02716 1.13517 0.05853 0
Total Equity 30.3801 32.5769 28.2662 28.9913 21.7443
Common Stock 0.78142 0.78142 0.7299 0.7299 0.56627
Additional Paid-In Capital 35.9784 35.6924 31.3721 31.1319 22.6956
Retained Earnings (Accumulated Deficit) -6.2325 -3.73869 -3.6604 -2.63829 -1.3427
Treasury Stock - Common -0.14723 -0.15817 -0.17539 -0.18834 -0.20495
Other Equity, Total 0 -0.0439 0.03016
Total Liabilities & Shareholders’ Equity 44.8606 44.4657 40.3496 38.6918 32.7308
Total Common Shares Outstanding 7.74686 7.74186 7.21884 7.21292 5.56896
Property/Plant/Equipment, Total - Gross 46.512 41.996 39.6407 34.8769
Accumulated Depreciation, Total -15.8756 -13.9933 -11.6653 -9.61119
Accounts Payable 0.79 0.74504 0.60235 0.57218
Accrued Expenses 1.09387 0.776 0.71091 0.47328
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 11.9621 10.9455 12.2483 13.9948 16.4331
Cash and Short Term Investments 1.98946 1.45431 3.09605 5.79156 8.82777
Cash & Equivalents 1.98946 1.45431 3.09605 5.79156 8.82777
Short Term Investments
Total Receivables, Net 2.0095 1.52199 2.14209 1.80078 1.73512
Accounts Receivable - Trade, Net 1.86459 1.49885 2.0903 1.7586 1.70183
Total Inventory 7.38566 7.53598 6.32833 6.03854 5.31778
Prepaid Expenses 0.57748 0.43324 0.68183 0.36388 0.55243
Other Current Assets, Total
Total Assets 44.545 44.0071 43.1232 44.8606 46.4016
Property/Plant/Equipment, Total - Net 32.3743 32.8358 30.639 30.6364 29.7862
Property/Plant/Equipment, Total - Gross 50.1882 49.9952 47.1328 46.512 45.6052
Accumulated Depreciation, Total -17.8138 -17.1594 -16.4937 -15.8756 -15.819
Goodwill, Net 0.09556 0.09556 0.09556 0.09556 0.09556
Intangibles, Net 0.04298 0.04776 0.05254 0.05731 0.06209
Other Long Term Assets, Total 0.07004 0.08246 0.08778 0.07663 0.02457
Total Current Liabilities 3.32797 4.19313 3.83793 3.07207 2.715
Accounts Payable 0.77985 0.9184 0.79485 0.79 0.75934
Accrued Expenses 0.92972 1.09283 0.84081 1.09387 0.69158
Notes Payable/Short Term Debt 0 1 1 0 0
Current Port. of LT Debt/Capital Leases 1.41123 1.0904 1.06423 1.03945 0.99816
Other Current Liabilities, Total 0.20718 0.0915 0.13804 0.14876 0.26592
Total Liabilities 18.5315 17.15 14.9621 14.4806 14.419
Total Long Term Debt 10.9047 8.64072 8.91687 9.19111 9.47868
Long Term Debt 10.9047 8.64072 8.91687 9.19111 9.47868
Other Liabilities, Total 4.29882 4.31616 2.20728 2.21742 2.22536
Total Equity 26.0135 26.8571 28.1611 30.3801 31.9825
Common Stock 0.78142 0.78142 0.78142 0.78142 0.78142
Additional Paid-In Capital 36.2466 36.1501 36.0745 35.9784 35.913
Retained Earnings (Accumulated Deficit) -10.8673 -9.92727 -8.54755 -6.2325 -4.56463
Treasury Stock - Common -0.14723 -0.14723 -0.14723 -0.14723 -0.14723
Total Liabilities & Shareholders’ Equity 44.545 44.0071 43.1232 44.8606 46.4016
Total Common Shares Outstanding 7.74686 7.74686 7.74686 7.74686 7.74686
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -2.49381 -0.07829 -1.02212 -1.29559 -2.32167
Cash From Operating Activities -1.54387 0.95417 1.31558 0.23351 -0.3734
Cash From Operating Activities 2.46848 2.44204 2.32818 2.24832 1.50161
Amortization 0.0191 0.0191 0.0191 0.0191 0.0191
Deferred Taxes 0 -0.01463 0.02468 0.46232
Non-Cash Items 0.29504 0.19383 -0.52722 0.33259 -0.33742
Cash Taxes Paid 0.00492 0.00511 0.00458 0.00357 0.00422
Cash Interest Paid 0.33852 0.30868 0.48141 0.42096 0.40354
Changes in Working Capital -1.83269 -1.62251 0.53226 -1.0956 0.30266
Cash From Investing Activities -3.96427 -1.59736 -2.56994 -3.40336 -1.79397
Capital Expenditures -3.97527 -2.60865 -4.07254 -1.39145 -2.0299
Other Investing Cash Flow Items, Total 0.011 1.01129 1.5026 -2.01191 0.23592
Cash From Financing Activities 1.11424 3.87872 1.91101 6.94209 0.88962
Financing Cash Flow Items -0.01931 0.00227 -0.05314 -0.00197
Issuance (Retirement) of Stock, Net 0.03067 4.24472 0.00001 8.30344 0.09625
Issuance (Retirement) of Debt, Net 1.10288 -0.36827 1.96413 -1.36135 0.79533
Net Change in Cash -4.39391 3.23553 0.65664 3.77224 -1.27776
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -2.31505 -2.49381 -0.82594 0.05152 0.73567
Cash From Operating Activities -2.76199 -1.54387 -0.24605 1.01199 0.63854
Cash From Operating Activities 0.65213 2.46848 1.869 1.24146 0.61685
Amortization 0.00478 0.0191 0.01433 0.00955 0.00478
Deferred Taxes
Non-Cash Items 0.11487 0.29504 0.2016 0.11255 0.04908
Cash Interest Paid 0.08804 0.33852 0.2473 0.1594 0.07188
Changes in Working Capital -1.21872 -1.83269 -1.50503 -0.40309 -0.76783
Cash From Investing Activities -0.68215 -3.96427 -2.4741 -1.73979 -0.7965
Capital Expenditures -0.68217 -3.97527 -2.4851 -1.75079 -0.8075
Other Investing Cash Flow Items, Total 0.00002 0.011 0.011 0.011 0.011
Cash From Financing Activities 0.74862 1.11424 1.36245 1.58555 1.78963
Financing Cash Flow Items 0 -0.01931 -0.01931 -0.01931 -0.01883
Issuance (Retirement) of Stock, Net 0 0.03067 0.03067 0.03067 0.00584
Issuance (Retirement) of Debt, Net 0.74862 1.10288 1.35108 1.57418 1.80262
Net Change in Cash -2.69551 -4.39391 -1.3577 0.85776 1.63167
Cash Taxes Paid 0.00721 0.00492 0.00458 0.00458 0.00554
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Pessin (Norman H) Individual Investor 8.3133 644019 -59617 2023-04-14 LOW
Rothschild (Jonathan E) Individual Investor 6.635 514003 0 2023-04-14 LOW
Pessin (Sandra F) Individual Investor 5.1869 401819 0 2023-04-14 LOW
Brigham (Michael F) Individual Investor 2.785 215752 0 2023-04-14 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.6633 206325 0 2023-06-30 LOW
Crabb (Joseph H) Individual Investor 1.8439 142845 0 2023-04-14 LOW
Pessin (Brian L) Individual Investor 1.7669 136882 26200 2023-04-14 LOW
Renaissance Technologies LLC Hedge Fund 1.5799 122389 -438 2023-06-30 HIGH
Tomsche (David Scott) Individual Investor 1.3374 103606 3100 2023-09-06 LOW
Bleichroeder LP Investment Advisor 1.3114 101594 0 2023-06-30 LOW
Cresset Asset Management, LLC Investment Advisor/Hedge Fund 1.2974 100506 0 2023-06-30 HIGH
Morgan Stanley Smith Barney LLC Investment Advisor 0.9678 74974 3600 2023-06-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.8295 64264 -425 2023-06-30 LOW
Shufro, Rose & Co., LLC Investment Advisor 0.8056 62408 0 2023-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5903 45727 7645 2023-06-30 LOW
Empire Financial Management Company, LLC Investment Advisor 0.5422 42000 0 2023-06-30 LOW
Overbrook Management Corporation Investment Advisor 0.4241 32857 0 2023-06-30
Strategic Financial Services, Inc. Investment Advisor 0.4002 31000 0 2023-06-30 LOW
Perritt Capital Management, Inc. Investment Advisor 0.3489 27026 -2649 2023-06-30 LOW
Hightower Advisors, LLC Investment Advisor 0.2756 21354 0 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

ImmuCell Company profile

About ImmuCell Corporation

ImmuCell Corporation is an animal health company. The Company is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. It expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The Company is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.

Financial summary

BRIEF: For the nine months ended 30 September 2021, ImmuCell Corporation revenues increased 19% to $13.8M. Net loss decreased 87% to $152K. Revenues reflect First Defense® product line segment increase of 44% to $9.5M, Other animal health segment increase of 83% to $186K, United States segment increase of 18% to $12.2M, Others segment increase of 28% to $1.6M.

Equity composition

Common Stock $.10 Par, 12/10, 8M auth., 3,261,148 issd., less 287,496 shs. in Treas. @ $635K. Insiders own 26.70%. PO 5/87, 966,000 Units (100 Common + 5 Warrants) @ $7/Unit by Stuart James. 7/90, 1-for-100 reverse stock split.

Industry: Biotechnology & Medical Research (NEC)

56 Evergreen Drive
PORTLAND
MAINE 04103
US

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

US100

16,219.10 Price
+0.880% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

1,981.42 Price
-1.180% 1D Chg, %
Long position overnight fee -0.0201%
Short position overnight fee 0.0118%
Overnight fee time 22:00 (UTC)
Spread 0.50

BTC/USD

40,845.85 Price
-6.830% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

XRP/USD

0.62 Price
-7.230% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading